GCP

GSA Capital Partners Portfolio holdings

AUM $1.16B
1-Year Est. Return 20.35%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+20.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,179
New
Increased
Reduced
Closed

Top Buys

1 +$6.99M
2 +$4.91M
3 +$4.83M
4
LNG icon
Cheniere Energy
LNG
+$4.74M
5
MBLY icon
Mobileye
MBLY
+$4.61M

Top Sells

1 +$6.32M
2 +$5.44M
3 +$3.77M
4
QRVO icon
Qorvo
QRVO
+$3.63M
5
FYBR
Frontier Communications
FYBR
+$3.58M

Sector Composition

1 Healthcare 16.3%
2 Technology 15.83%
3 Financials 13.37%
4 Industrials 12.59%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EM
1601
Smart Share Global Ltd
EM
$297M
$19K ﹤0.01%
+16,362
SKYE icon
1602
Skye Bioscience
SKYE
$31.6M
$17K ﹤0.01%
+22,877
CGTX icon
1603
Cognition Therapeutics
CGTX
$113M
$16K ﹤0.01%
11,843
-184,514
WWR icon
1604
Westwater Resources
WWR
$84.8M
$16K ﹤0.01%
21,063
-115,237
ARAY icon
1605
Accuray
ARAY
$53.8M
$15K ﹤0.01%
18,139
-62,562
PAVM icon
1606
PAVmed
PAVM
$57.9M
$15K ﹤0.01%
+2,197
PRTS icon
1607
CarParts.com
PRTS
$73.6M
$15K ﹤0.01%
30,832
-532,971
SUNE
1608
SUNation Energy
SUNE
$4.22M
$15K ﹤0.01%
+15,035
BCDA icon
1609
BioCardia
BCDA
$12.8M
$14K ﹤0.01%
+11,303
PZG icon
1610
Paramount Gold Nevada
PZG
$141M
$14K ﹤0.01%
+11,338
ATER icon
1611
Aterian
ATER
$7.67M
$13K ﹤0.01%
18,137
-1,246
KUST
1612
Kustom Entertainment Inc
KUST
$2.25M
$13K ﹤0.01%
+6,725
MBIO icon
1613
Mustang Bio
MBIO
$5.78M
$13K ﹤0.01%
+12,834
RLYB icon
1614
Rallybio
RLYB
$45M
$13K ﹤0.01%
+2,413
TOUR
1615
Tuniu
TOUR
$728M
$13K ﹤0.01%
+20,598
MYPS icon
1616
PLAYSTUDIOS Inc
MYPS
$57.2M
$11K ﹤0.01%
16,713
-70,286
VFC icon
1617
VF Corp
VFC
$7.83B
-74,159
VHT icon
1618
Vanguard Health Care ETF
VHT
$16.2B
-1,820
VLN icon
1619
Valens Semiconductor
VLN
$174M
-44,499
VLO icon
1620
Valero Energy
VLO
$69.9B
-3,209
VLTO icon
1621
Veralto
VLTO
$21.8B
-3,127
GGRP
1622
Glimpse Group
GGRP
$12.2M
-26,683
VRSK icon
1623
Verisk Analytics
VRSK
$23.2B
-6,680
VRTX icon
1624
Vertex Pharmaceuticals
VRTX
$111B
-569
VTGN icon
1625
VistaGen Therapeutics
VTGN
$22.6M
-31,486